Attached files

file filename
8-K/A - AMENDMENT TO FORM 8-K - Majescoea122755-8ka1_majesco.htm

Exhibit 99.1

 

Majesco and Subsidiaries

 

Consolidated Statements of Operations (Unaudited)
(All amounts are in thousands of US Dollars except per share data and as stated otherwise)

 

   Three
months
ended
March 31,
2020
   Three  
months  
ended  
March 31,
2019
   Twelve  
months  
ended  
March 31,
2020
   Twelve
months  
Ended  
March 31,
2019
 
Revenue  $37,911   $37,190   $146,445   $141,307 
Cost of revenue   19,674    19,140    74,804    72,480 
Gross profit  $18,237   $18,050   $71,641   $68,827 
                     
Operating expenses                    
Research and development expenses  $4,429   $5,018   $19,068   $19,399 
Selling, general and administrative expenses   10,611    10,659    42,340    39,702 
Exceptional Item – M&A Expenses   725    2    725    444 
Total operating expenses  $15,765   $15,679   $62,133   $59,545 
Income/(Loss) from operations  $2,472   $2,371   $9,508   $9,282 
Interest income   125    72    616    104 
Interest expense   (81)   (108)   (350)   (450)
Gain on reversal of accrued contingent liability   1,473        2,832    835 
Other income (expenses), net   647    (112)   1,225    441 
Income /(Loss) before provision for income taxes  $4,636   $2,223   $13,831   $10,212 
(Benefit)/Provision for income taxes   1,021    1,004    4,151    3,547 
Net Income/(Loss)  $3,615   $1,219   $9,680   $6,665 
                     
Earnings (Loss) per share:                    
Basic  $0.08   $0.03   $0.22   $0.19 
Diluted  $0.08   $0.03   $0.21   $0.18 
                     
Weighted average number of common shares outstanding                    
Basic   43,250,530    38,972,051    43,056,910    37,209,999 
Diluted   45,087,888    41,216,279    45,258,965    39,273,605 

 

 

 

 

Majesco and Subsidiaries

Consolidated Balance Sheets (Unaudited)

(All amounts are in thousands of U.S. Dollars except per share data and as stated otherwise)

 

  

March 31,

2020

  

March 31,

2019

 
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents  $35,240   $11,329 
Short term investments   16,173    28,108 
Restricted cash   39    43 
Accounts receivables, net   26,156    17,366 
Unbilled accounts receivable   16,118    17,916 
Prepaid expenses and other current assets   7,266    15,598 
Total current assets   100,992    90,360 
Property and equipment, net   2,132    3,026 
Operating lease right-of-use asset, net   2,977     
Intangible assets, net   9,531    12,969 
Deferred income tax assets   8,162    7,816 
Unbilled accounts receivable   847    543 
Other assets   1,745    489 
Goodwill   32,981    34,145 
Total Assets  $159,367   $149,348 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Software hire purchase obligation        
Short term debt   25    442 
Current maturities of long-term borrowings        
Accounts payable   4,159    2,327 
Operating lease right-of-use liability   1,428     
Accrued expenses and other liabilities   22,599    34,871 
Deferred revenue   20,553    10,988 
Total current liabilities   48,764    48,628 
Long term debt        
Vehicle loan   68    109 
Operating lease right-of-use liability, net of current portion   1,580     
Other   2,342    4,040 
Total Liabilities  $52,754   $52,777 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, par value $0.002 per share – 50,000,000 shares authorized as of March 31, 2020 and March 31, 2019, and no shares issued and outstanding as of March 31, 2020 and March 31, 2019        
Common stock, par value $0.002 per share – 450,000,000 shares authorized as of March 31, 2020 and March 31, 2019; 43,285,428  shares issued and outstanding as of March 31, 2020 and 42,846,273 as of March 31, 2019  $87   $86 
Additional paid-in capital   126,643    122,163 
Accumulated deficit   (16,385)   (26,499)
Accumulated other comprehensive income   (3,732)   (412)
Non-Controlling Interest       1,233 
Total equity of common stockholder   106,613    95,571 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $159,367   $149,348 

 

2

 

 

Majesco and Subsidiaries

Reconciliation of U.S. GAAP Net Income to EBITDA and Adjusted EBITDA

(Unaudited)

 

  

Three Months Ended

March 31,

  

Twelve Months Ended

March 31,

 
(U.S. dollars; in thousands):  2020   2019   2020   2019 
Net Income (Loss)  $3,615   $1,219    9,680   $6,665 
                     
Add:                    
                     
Provision (benefit) for income taxes   1,021    1,004    4,151    3,547 
Depreciation and amortization   1,203    1,272    4,846    4,347 
                     
Interest expense   81    108    350    450 
                     
Less:                    
                     
Interest income   (125)   (72)   (616)   (104)
Other income (expenses), net   (647)   112    (1,225)   (441)
EBITDA  $5,148   $3,643   $17,186   $14,464 
                     
Add:                    
                     
Exceptional Items – M&A Costs   725    2    725    444 
Stock based compensation   714    765    2,884    2,944 
Reversal of accrual for contingent liability   (1,473)       (2,832)   (835)
                     
Adjusted EBITDA  $5,114   $4,410   $17,963   $17,017 
                     
Revenue   37,911    37,190    146,445    141,307 
Adjusted EBITDA as a % of Revenue   13.49%   11.86%   12.27%   12.04%

 

 

3